The power of foresight: How AI-enabled prediction can reduce the risk of nighttime lows

For many individuals, the transition from day to night brings a heightened sense of vulnerability. Nocturnal hypoglycemia, or low blood sugar during sleep, is a persistent challenge that can lead to poor sleep quality, anxiety, and in severe cases, dangerous health emergencies. This constant threat fuels a fear of nighttime lows that makes a peaceful night’s sleep feel impossible.

Recent global research highlights the scale of this burden: A full 71% of respondents say they are tired because of their diabetes, with 55% saying it negatively impacts their ability to fall asleep.1 This exhaustion is often caused by constantly managing glucose levels around the clock.2 

For many, like diabetes advocate Michelle Schmidt (CEO, Diability GmbH), the key is moving from reacting to events to preventing them."With predictive technology, I’m no longer just reacting to lows – I’m preventing them," she says. "It gives me the confidence to close my eyes and trust the insights I’m receiving, turning a night of worry into a night of rest".

The science of staying ahead

While traditional diabetes monitoring tells us what is happening now, the future of care lies in knowing what happens next. This means instead of a reactive alarm waking a person because their sugar has already dropped, the potential disruption is identified and managed ahead of time. This shift is powered by the Night Low Predict, AI-enabled technology designed to forecast the likelihood of hypoglycemia before it happens. 

By analyzing glucose patterns in real-time, the system used in the study provides a 7 hour "look-ahead" window that allows for proactive management before the person goes to sleep. The predictive logic uses three clear risk levels to guide the night ahead: a 'Normal' baseline (<30% probability), 'High' risk (30-60%), and 'Very High' risk (above 60%). When the algorithm identifies a high- or very high-risk window, it suggests simple, proactive steps – like a small snack or a slight insulin adjustment – to stop a low before it ever happens.

Real-world proof of better balance

The clinical impact of this predictive app was recently evaluated in a landmark retrospective analysis published in Diabetes Research and Clinical Practice. By analysing real-world data from 249 users with type 1, type 2 or other diabetes types, the study compared nights where this predictive intelligence was active against those where it was not. 

The findings were definitive:  

• 20% lower odds of experiencing any hypoglycemic event during the night.

• 31% reduction in the odds of severe Level 2 hypoglycemic events.

• Precision without compromise: Crucially, the reduction in lows was achieved without increasing the risk of nocturnal hyperglycemia (high blood sugar), a common concern when patients take proactive measures before sleep.

From data to foresight

This new era of intelligent diagnostics doesn't just collect data; it processes it in real-time to provide targeted guidance. By analyzing aggregated data from real-world users, Roche researchers proved that an AI-enabled predictive algorithm can successfully lower the odds of dangerous nocturnal events.3

"This evidence proves that targeted AI enabled guidance provides real utility," explains Guy Bogaarts, one of the study’s authors and a researcher at Roche. "We can now show that AI-driven insights empower users to take proactive bedtime measures that significantly help to lower the odds of potentially dangerous nighttime lows without causing the high glucose levels that doctors often fear."

"Smarter tools that predict glucose levels have the potential to help people like Michelle," says Guy. "They offer the confidence that comes with knowing you are staying within range, allowing users to feel more in control of their health rather than being managed by it."